Samaan Farid, Mendes Áquilas, Carnut Leonardo
Planning and Evaluation Group, São Paulo State Health Department, São Paulo, SP, Brazil.
Research Division, Dante Pazzanese Cardiology Institute, São Paulo, SP, Brazil.
Clinicoecon Outcomes Res. 2024 May 13;16:417-435. doi: 10.2147/CEOR.S464120. eCollection 2024.
Worldwide the assistance on renal replacement therapy (RRT) is carried out mainly by private for-profit services and in a market with increase in mergers and acquisitions. The aim of this study was to conduct an integrative systematic review on privatization and oligopolies in the RRT sector in the context of contemporary capitalism. The inclusion criteria were scientific articles without language restrictions and that addressed the themes of oligopoly or privatization of RRT market. Studies published before 1990 were excluded. The exploratory search for publications was carried out on February 13, 2024 on the Virtual Health Library Regional Portal (VHL). Using the step-by-step of PRISMA flowchart, 34 articles were retrieved, of which 31 addressed the RRT sector in the United States and 26 compared for-profit dialysis units or those belonging to large organizations with non-profit or public ones. The main effects of privatization and oligopolies, evaluated by the studies, were: mortality, hospitalization, use of peritoneal dialysis and registration for kidney transplantation. When considering these outcomes, 19 (73%) articles showed worse results in private units or those belonging to large organizations, six (23%) studies were in favor of privatization or oligopolies and one study was neutral (4%). In summary, most of the articles included in this systematic review showed deleterious effects of oligopolization and privatization of the RRT sector on the patients served. Possible explanations for this result could be the presence of conflicts of interest in the RRT sector and the lack of incentive to implement the chronic kidney disease care line. The predominance of articles from a single nation may suggest that few countries have transparent mechanisms to monitor the quality of care and outcomes of patients on chronic dialysis.
在全球范围内,肾脏替代治疗(RRT)援助主要由私营营利性服务机构提供,且该市场的并购活动不断增加。本研究旨在对当代资本主义背景下RRT领域的私有化和寡头垄断进行综合系统评价。纳入标准为无语言限制且涉及RRT市场寡头垄断或私有化主题的科学文章。1990年以前发表的研究被排除。2024年2月13日在虚拟健康图书馆区域门户(VHL)上进行了出版物的探索性检索。按照PRISMA流程图的步骤,检索到34篇文章,其中31篇涉及美国的RRT领域,26篇将营利性透析单位或大型组织所属的透析单位与非营利性或公立透析单位进行了比较。研究评估的私有化和寡头垄断的主要影响包括:死亡率、住院率、腹膜透析的使用以及肾移植登记情况。在考虑这些结果时,19篇(73%)文章显示私营单位或大型组织所属单位的结果更差,6篇(23%)研究支持私有化或寡头垄断,1篇研究持中立态度(4%)。总之,本系统评价纳入的大多数文章表明,RRT领域的寡头垄断和私有化对所服务的患者产生了有害影响。这一结果的可能解释可能是RRT领域存在利益冲突,以及缺乏实施慢性肾脏病护理流程的激励措施。来自单一国家的文章占主导地位可能表明,很少有国家拥有透明的机制来监测慢性透析患者的护理质量和治疗结果。